Sam Colman, MSc

Sam Colman, MSc, is a Senior Director and real-world evidence (RWE) biostatistician who co-leads the RWE & Analytics service within Fortrea’s Market Access Consulting and HEOR group.

John Carlsen, MHA

John Carlsen, MHA, is a Vice President who leads the Reimbursement Strategy & Payer Insights service within Fortrea’s Market Access Consulting and HEOR group.

Kristi Baum-Skorija, MBA

Kristi Baum-Skorija, MBA, is an Executive Director who leads reimbursement strategy projects within Fortrea’s Market Access Consulting and HEOR group.

Barbara Mascialino, PhD

Barbara Mascialino is a Senior Director who leads the Health Economic Modeling & HTA service within Fortrea’s Market Access Consulting and HEOR Consulting group.

Kathryn Plante, MS

Kathryn (Kate) Plante, MS, is a Vice President who leads Fortrea’s global Market Access Consulting and HEOR group.

The Industry’s Core Constraint Is No Longer Technology — It’s Execution

Reducing ‘white space’: Pursuing achievable efficiencies in clinical trials

Choosing the right FSP model for your clinical challenge: a practical guide